| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 5,945,358 | 5,710,649 | 5,763,526 | 5,619,536 | | Cost of Revenue | 1,683,937 | 1,562,013 | 1,691,418 | 1,617,581 | | | Gross Profit | 4,261,421 | 4,148,636 | 4,072,108 | 4,001,955 | | | Operating Expenses | | Research Development | 836,067 | 839,377 | 882,466 | 798,464 | | Selling General and Administrative | 1,832,500 | 1,722,213 | 1,882,476 | 1,670,671 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,592,854 | 1,587,046 | 1,307,166 | 1,532,820 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 25,992 | 170,941 | 752,449 | 101,038 | | Earnings Before Interest And Taxes | 1,618,846 | 1,757,987 | 2,059,615 | 1,633,858 | | Interest Expense |
-
|
-
| 696,583 |
-
| | Income Before Tax | 1,618,846 | 1,757,987 | 1,363,032 | 1,633,858 | | Income Tax Expense | 496,752 | 561,040 | 345,602 | 487,953 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,122,094 | 1,196,947 | 1,017,430 | 1,145,905 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,122,094 | 1,196,947 | 1,017,430 | 1,145,905 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,122,094 | $1,196,947 | $1,017,430 | $1,145,905 |
|
1.49% Nasdaq 
0.27%
Income Statement
